The International Workshop on HBV Cure 2024 | Hepatitis B Cure | Hepatitis

Hepatitis B Community Forum 2024Подробнее

Future Treatment of Hepatitis B | Future Treatments of Hepatitis | Hepatitis B CureПодробнее

TherVacB's Journey Against Hepatitis B | TherVacB: A Therapeutic Vaccine to Cure Hepatitis BПодробнее

Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCPПодробнее

Latest Updates on Novel Biomarkers in HBV Cure - Man-Fung Yuen, MBBS, MD, PhD, DScПодробнее

Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg (...) ? - Michael J. Sofia, PhDПодробнее

Second Generation CAMs Leading to HBsAg Decline - Matthew McClure, MDПодробнее

International Workshop on HBV Cure 2024 - Promo VideoПодробнее

20 Selected HBV-related Abstracts Being Presented at AASLD 2023 - Adam Gehring, PhDПодробнее

Efficacy and Safety of Targeting PD-L1 with Monoclonal Antibodies - Jinzi J. Wu, PhDПодробнее

Immunological Profiles Induced by New Therapeutic Vaccines - Eleanor Barnes, PhD, FRCP, F. Med. Sci.Подробнее

Next Generation CAMs, New Life for Small Molecules? - Mark Sulkowski, MDПодробнее

Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhDПодробнее

Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPHПодробнее

Expanding CHB Treatment Criteria with Nucs as Prelude of Novel (...) ? - Harry Janssen, MD, PhDПодробнее

Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhDПодробнее

Value of Adding Recombinant Antigens to Viral Vector Vaccines - Ventzi Vassilev, PhDПодробнее

Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MDПодробнее

Durability of Response After DAA Therapies - Fabien Zoulim, MD, PhDПодробнее